ResMed Amends Proxy Statement for Nov. 21 Annual Meeting

TL;DR

ResMed filed an amendment to its proxy statement for the Nov 21st annual meeting. Check the latest filings for details.

AI Summary

ResMed Inc. filed an amendment to its definitive proxy statement on October 25, 2024, for its annual meeting of stockholders scheduled for November 21, 2024. This amendment updates the proxy materials previously filed on October 3, 2024, but does not provide specific details on the changes within this filing excerpt. The company is seeking shareholder approval for matters to be discussed at the annual meeting.

Why It Matters

This filing is important as it contains updated information and proposals that shareholders will vote on at the upcoming annual meeting, impacting corporate governance and future company direction.

Risk Assessment

Risk Level: low — This is a routine amendment to a proxy statement, providing updated information for an upcoming shareholder meeting.

Key Players & Entities

• RESMED INC (company) — Registrant
• October 25, 2024 (date) — Filing date of amendment
• November 21, 2024 (date) — Date of annual meeting
• October 3, 2024 (date) — Date of original proxy statement

FAQ

Filing Documents

• d874844ddefa14a.htm (DEFA14A) — 9KB
• g874844g1025103453881.jpg (GRAPHIC) — 4KB
• 0001193125-24-244162.txt ( ) — 15KB

From the Filing

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14A-12 (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. AMENDMENT TO PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS TO BE HELD NOVEMBER 21, 2024 This document is an amendment (Amendment) to our Proxy Statement dated October 3, 2024, and furnished in connection with the Annual Meeting of Stockholders of ResMed Inc., which will be held on Thursday, November 21, 2024, at 8:30 a.m. Singapore Time and 11:30 a.m. Australian Eastern Time, which is Wednesday, November 20, 2024, at 4:30 p.m. US Pacific Time. EXPLANATORY STATEMENT Due to a scriveners error, the telephone number to vote and website address where our proxy statement and the annual report may be accessed was incorrectly stated in the Notice of Annual Meeting of Stockholders. The correct telephone number to vote by phone is 1-800-690-6903 and the correct website address to access our proxy statement and annual report is htttp://investors.resmed.com. Except as specifically revised by the information contained in this Amendment, this Amendment does not modify, amend, supplement, or otherwise affect any matter presented for consideration in, or other information set forth in, the Proxy Statement.

View Full Filing

View this DEFA14A filing on SEC EDGAR